antibodies to tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies Effects of tirzepatide, a dual

The North Carolina State Health Plan board of trustees will consider dropping coverage of GLP-1 medications like Wegovy and Saxenda

The TRIUMPH clinical development program evaluates its safety and efficacy ...

In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither outsourcing compounding pharmacies or pharmacies could compound drugs that were essentially copies of either semaglutide (available under the brand names Ozempic, Rybelsus, and Wegovy) and tirzepatide (available under the brand names Mounjaro, and Zepbound).

For weeks 14: Start with 2 mg (0.13 mL or 13 units) to assess tolerance

Interested in learning more about two weight loss medications

Breaking news and video